Tellgen Corp Market Cap ($374.23 Million)
Market Cap & Net Worth: Tellgen Corp (300642)
Tellgen Corp market cap. Tellgen Corp (SHE:300642) has a market capitalization of $374.23 Million (CN¥2.56 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #13469 globally and #3960 in its home market, demonstrating a -0.63% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tellgen Corp's stock price CN¥15.76 by its total outstanding shares 162272241 (162.27 Million). Also see Tellgen Corp cash conversion from operations for how efficiently the company converts equity into cash flow.
Tellgen Corp Market Cap History (2017–2026)
Tellgen Corp market cap history from 2017 to 2026. Data shows change from $764.15 Million to $374.23 Million (-1.48% CAGR). Check Tellgen Corp stock quote for real-time trading data and today's change.
Tellgen Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tellgen Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Tellgen Corp (300642) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.20x
Tellgen Corp's market cap is 1.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
121.71x
Tellgen Corp's market cap is 121.71 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $764.15 Million | $302.89 Million | $126.81 Million | 2.52x | 6.03x |
| 2018 | $474.64 Million | $364.85 Million | $141.69 Million | 1.30x | 3.35x |
| 2019 | $520.20 Million | $441.45 Million | $157.02 Million | 1.18x | 3.31x |
| 2020 | $730.31 Million | $489.58 Million | $120.55 Million | 1.49x | 6.06x |
| 2021 | $729.97 Million | $654.59 Million | $161.08 Million | 1.12x | 4.53x |
| 2022 | $484.05 Million | $715.97 Million | $124.76 Million | 0.68x | 3.88x |
| 2023 | $414.79 Million | $542.81 Million | $89.40 Million | 0.76x | 4.64x |
| 2024 | $335.29 Million | $436.78 Million | $34.53 Million | 0.77x | 9.71x |
| 2025 | $436.68 Million | $363.83 Million | $3.59 Million | 1.20x | 121.71x |
Competitor Companies of 300642 by Market Capitalization
Companies near Tellgen Corp in the global market cap rankings as of November 5, 2026. Also see Tellgen Corp balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Tellgen Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Tellgen Corp (2017–2026)
Market capitalization of Tellgen Corp from 2017 to today. Between 2017 and today, Tellgen Corp's market cap moved from $764.15 Million to $ 374.23 Million, with a yearly change of -1.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥374.23 Million | -14.30% |
| 2025 | CN¥436.68 Million | +30.24% |
| 2024 | CN¥335.29 Million | -19.17% |
| 2023 | CN¥414.79 Million | -14.31% |
| 2022 | CN¥484.05 Million | -33.69% |
| 2021 | CN¥729.97 Million | -0.05% |
| 2020 | CN¥730.31 Million | +40.39% |
| 2019 | CN¥520.20 Million | +9.60% |
| 2018 | CN¥474.64 Million | -37.89% |
| 2017 | CN¥764.15 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Tellgen Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $374.23 Million USD |
| MoneyControl | $374.23 Million USD |
| MarketWatch | $374.23 Million USD |
| marketcap.company | $374.23 Million USD |
| Reuters | $374.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tellgen Corp
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more